Mihael Hristos Polymeropoulos Vanda Pharmaceuticals Inc. (VNDA) insider trading activity

Mihael Hristos Polymeropoulos is President and CEO of Vanda Pharmaceuticals Inc.. Currently has a direct ownership of 2.3 Million shares of VNDA, which is worth approximately $10.8 Million. The most recent transaction as insider was on Mar 06, 2025, when has been sold 10,000 shares (Common Stock) at a price of $5.02 per share, resulting in proceeds of $50,199. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.3M

22.65% 3M change

22.65% 12M change

Total Value Held $10.8 Million

Mihael Hristos Polymeropoulos Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 06 2025	BUY Open market or private purchase	$50,199 $5.02 p/Share	10,000 Added 0.43%	2,295,731 Common Stock
Mar 05 2025	BUY Open market or private purchase	$50,199 $5.02 p/Share	10,000 Added 0.44%	2,285,731 Common Stock
Mar 03 2025	BUY Open market or private purchase	$47,000 $4.7 p/Share	10,000 Added 0.44%	2,275,731 Common Stock
Mar 01 2025	SELL Payment of exercise price or tax liability	$456,955 $4.76 p/Share	95,999 Reduced 4.06%	2,265,731 Common Stock
Feb 28 2025	BUY Open market or private purchase	$47,600 $4.76 p/Share	10,000 Added 0.42%	2,361,730 Common Stock
Feb 27 2025	BUY Open market or private purchase	$47,600 $4.76 p/Share	10,000 Added 0.42%	2,351,730 Common Stock
Feb 26 2025	BUY Open market or private purchase	$47,699 $4.77 p/Share	10,000 Added 0.43%	2,341,730 Common Stock
Feb 25 2025	BUY Open market or private purchase	$44,600 $4.46 p/Share	10,000 Added 0.43%	2,331,730 Common Stock
Feb 18 2025	BUY Grant, award, or other acquisition	-	450,000 Added 16.24%	2,321,730 Common Stock
Mar 05 2024	SELL Open market or private sale	$100,309 $4.13 p/Share	24,288 Reduced 1.28%	1,871,730 Common Stock
Mar 04 2024	SELL Open market or private sale	$130,948 $4.24 p/Share	30,884 Reduced 1.6%	1,896,018 Common Stock
Feb 16 2024	BUY Grant, award, or other acquisition	-	450,000 Added 18.93%	1,926,902 Common Stock
Mar 03 2023	SELL Open market or private sale	$140,862 $6.25 p/Share	22,538 Reduced 1.5%	1,476,902 Common Stock
Mar 02 2023	SELL Open market or private sale	$139,713 $6.23 p/Share	22,426 Reduced 1.47%	1,499,440 Common Stock
Feb 16 2023	BUY Grant, award, or other acquisition	-	115,000 Added 7.03%	1,521,866 Common Stock
Dec 06 2022	SELL Open market or private sale	$511,932 $10.61 p/Share	48,250 Reduced 3.32%	1,406,866 Common Stock
Dec 06 2022	BUY Exercise of conversion of derivative security	$235,138 $3.12 p/Share	75,365 Added 4.92%	1,455,116 Common Stock
Dec 05 2022	SELL Open market or private sale	$506,042 $10.62 p/Share	47,650 Reduced 3.34%	1,379,751 Common Stock
Dec 05 2022	BUY Exercise of conversion of derivative security	$232,861 $3.12 p/Share	74,635 Added 4.97%	1,427,401 Common Stock
Mar 02 2022	SELL Open market or private sale	$329,906 $11.15 p/Share	29,588 Reduced 2.14%	1,352,766 Common Stock
Mar 01 2022	SELL Open market or private sale	$84,015 $11.19 p/Share	7,508 Reduced 0.54%	1,382,354 Common Stock
Feb 28 2022	BUY Grant, award, or other acquisition	-	115,000 Added 7.64%	1,389,862 Common Stock
Dec 01 2021	SELL Open market or private sale	$739,200 $16.0 p/Share	46,200 Reduced 3.5%	1,274,862 Common Stock
Dec 01 2021	BUY Exercise of conversion of derivative security	$349,779 $4.88 p/Share	71,676 Added 5.15%	1,321,062 Common Stock
Nov 30 2021	SELL Open market or private sale	$824,500 $16.49 p/Share	50,000 Reduced 3.85%	1,249,386 Common Stock

MHP

Mihael Hristos Polymeropoulos

President and CEO

Washington, DC

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VNDA shares.

Notify only if

Value

Insider Trading

Get notified when an Vanda Pharmaceuticals Inc. insider buys or sells VNDA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Vanda Pharmaceuticals Inc.

Track Activities on VNDA

Account